Cargando…
The cost of biologics for psoriasis is increasing
BACKGROUND: Biologic agents have revolutionized the management of psoriasis but at a higher cost compared with “traditional” agents. Cost must be considered when evaluating management options for psoriasis. OBJECTIVE: To estimate the annual cost of treatment of psoriasis using biologic agents and as...
Autores principales: | Cheng, Judy, Feldman, Steven R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Just Medical Media Limited
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295913/ https://www.ncbi.nlm.nih.gov/pubmed/25598832 http://dx.doi.org/10.7573/dic.212266 |
Ejemplares similares
-
Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United States
por: Feldman, Steven R., et al.
Publicado: (2018) -
Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis
por: Cline, Abigail, et al.
Publicado: (2019) -
The Costs of Psoriasis Medications
por: Mustonen, Anssi, et al.
Publicado: (2013) -
Treatment Sequencing After Failure of the First Biologic in Cost-Effectiveness Models of Psoriasis: A Systematic Review of Published Models and Clinical Practice Guidelines
por: Mauskopf, Josephine, et al.
Publicado: (2014) -
Improving management of psoriasis patients receiving biological treatment: A qualitative approach
por: Trettin, Bettina, et al.
Publicado: (2021)